Liu, Suxing
Liu, Dong
Shen, Ru
Li, Di
Hu, Qiyue
Yan, Yinfa
Sun, Jiakang
Zhang, Fengqi
Wan, Hong
Dong, Ping
Feng, Jun
Zhang, Rumin
Li, Jing
Zhang, Lianshan
Tao, Weikang
Funding for this research was provided by:
Shanghai Hengrui Pharmaceutical Co. Ltd.
Article History
Received: 20 January 2021
Accepted: 13 April 2021
First Online: 28 April 2021
Competing interests
: S.L., R.S., D.L.<sup>1</sup>, D.L.<sup>2</sup>, Y.Y., F.Z., R.Z., J.L. were employees of Eternity Bioscience Inc. and J.S., Q.H., H.W., P.D., J.F., L.Z., W.T. were employees and shareholders of Hengrui Pharmaceutical Co. Ltd. D.L.<sup>1</sup> = Dong Liu; D.L.<sup>2</sup> = Di Li.